Literature DB >> 8463417

Bile reflux and intestinal metaplasia in gastric mucosa.

G M Sobala1, H J O'Connor, E P Dewar, R F King, A T Axon, M F Dixon.   

Abstract

AIM: To determine associations between enterogastric bile reflux and gastric mucosal pathology.
METHOD: A retrospective study using fasting gastric juice bile acid measurements and antral or prestomal biopsy specimens from 350 patients, 66 of whom had previously undergone surgery that either bypassed or disrupted the pyloric sphincter.
RESULTS: Bile reflux was positively associated with reactive gastritis and negatively with Helicobacter pylori density. After stratification for previous surgery, age, and H pylori status, the histological feature most strongly associated with bile reflux was intestinal metaplasia, including all its subtypes. The prevalence of intestinal metaplasia was greatest in patients with both H pylori infection and high bile acid concentrations. Bile reflux was also positively associated with the severity of glandular atrophy, chronic inflammation, lamina propria oedema and foveolar hyperplasia.
CONCLUSIONS: Bile reflux is a cause of reactive gastritis. It modifies the features of H pylori associated chronic gastritis. The changes are not confined to patients who have had surgery to their stomachs. The positive associations with atrophy and intestinal metaplasia have implications for models of gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8463417      PMCID: PMC501177          DOI: 10.1136/jcp.46.3.235

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  Histology of alcoholic hemorrhagic "gastritis": a prospective evaluation.

Authors:  L Laine; W M Weinstein
Journal:  Gastroenterology       Date:  1988-06       Impact factor: 22.682

2.  Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study.

Authors:  S Silva; M I Filipe; A Pinho
Journal:  Gut       Date:  1990-10       Impact factor: 23.059

3.  Gastric histology and fasting bile reflux after partial gastrectomy.

Authors:  P Bechi; A Amorosi; R Mazzanti; P Romagnoli; L Tonelli
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

4.  Histology of the postoperative stomach before and after diversion of bile.

Authors:  P C Watt; J M Sloan; A Spencer; T L Kennedy
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-12

5.  Histopathogenesis of intestinal metaplasia: minute lesions of intestinal metaplasia in ulcerated stomachs.

Authors:  K Mukawa; T Nakamura; G Nakano; Y Nagamachi
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

6.  Bile reflux and degree of gastritis in patients with gastric ulcer: before and after operation.

Authors:  P Dewar; M F Dixon; D Johnston
Journal:  J Surg Res       Date:  1984-10       Impact factor: 2.192

7.  Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH.

Authors:  A Morris; G Nicholson
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

8.  Intragastric bile acids and scintigraphy in the assessment of duodenogastric reflux.

Authors:  P W Houghton; N J Mortensen; W E Thomas; M J Cooper; A P Morgan; E R Davies
Journal:  Br J Surg       Date:  1986-04       Impact factor: 6.939

9.  Reflux gastritis: distinct histopathological entity?

Authors:  M F Dixon; H J O'Connor; A T Axon; R F King; D Johnston
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

10.  Prospective evaluation of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia.

Authors:  J A Kovacs; V Gill; J C Swan; F Ognibene; J Shelhamer; J E Parrillo; H Masur
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

View more
  61 in total

1.  Reproducibility and intragastric variation of duodenogastric reflux using ambulatory gastric bilirubin monitoring.

Authors:  D K Manifold; A Anggiansah; R E Marshall; W J Owen
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Cell proliferation in the post-surgical stomach, dietary salt, and the effect of H pylori eradication.

Authors:  P Willis; D A Lynch; R Prescott; S Lamonby
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

Review 3.  How is it possible to prevent gastric mucosal injury and remnant cancer after distal gastrectomy?

Authors:  Michio Kaminishi
Journal:  J Gastroenterol       Date:  2005-06       Impact factor: 7.527

Review 4.  Helicobacter pylori infection following partial gastrectomy for gastric cancer.

Authors:  Sanghoon Park; Hoon Jai Chun
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

5.  Any role left for invasive tests? Histology in clinical practice.

Authors:  P Moayyedi; M F Dixon
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

6.  Roux-en-Y reconstruction after distal gastrectomy to reduce enterogastric reflux and Helicobacter pylori infection.

Authors:  De-Chuan Chan; Yu-Ming Fan; Chih-Kung Lin; Cheng-Jueng Chen; Ching-Yuan Chen; You-Chen Chao
Journal:  J Gastrointest Surg       Date:  2007-09-18       Impact factor: 3.452

7.  Primary duodenogastric reflux in children and adolescents.

Authors:  Dominique Hermans; Etienne-Marc Sokal; Jean-Marie Collard; Renato Romagnoli; Jean-Paul Buts
Journal:  Eur J Pediatr       Date:  2003-06-26       Impact factor: 3.183

8.  Bile reflux gastritis and intestinal metaplasia at the cardia.

Authors:  M F Dixon; N P Mapstone; P M Neville; P Moayyedi; A T R Axon
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

9.  Gallstones increase the prevalence of Barrett's esophagus.

Authors:  Juntaro Matsuzaki; Hidekazu Suzuki; Keiko Asakura; Yoshimasa Saito; Kenro Hirata; Toru Takebayashi; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2009-11-12       Impact factor: 7.527

Review 10.  Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons.

Authors:  Gregory Y Lauwers; Hiroshi Fujita; Koji Nagata; Michio Shimizu
Journal:  J Gastroenterol       Date:  2009-12-05       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.